International Academy for Clinical Hematology IACH
- 58:38
- 14 күн бұрын
Considerations for Conditioning Chemotherapy Dosing in Obesity
- 42:46
- 21 күн бұрын
How do I Assess Frailty Prior to Stem Cell Transplantation?
- 1:10:13
- 28 күн бұрын
joint IACRLRD/IACH webinar: Mastoctocytosis from dogs to humans
- 49:44
- 28 күн бұрын
TMA and Stem Cell Transplantation: From Diagnosis to Therapy
- 56:01
- Ай бұрын
Sickle cell disease landscape and challenges
- 1:01:08
- Ай бұрын
Bispecific Antibodies in Lymphoma
- 52:56
- Ай бұрын
State of the Art Management of Follicular Lymphoma
- 25:13
- Ай бұрын
COMy 2024: KOL Interview
- 51:23
- Ай бұрын
Oui, on a la vie devant soi (In French)
- 1:10:48
- Ай бұрын
Post EBMT 2024 in French
- 1:02:08
- Ай бұрын
Allogeneic Stem Cell Transplantation for Myelofibrosis
- 1:08:16
- Ай бұрын
Curative Therapies for Transfusion Dependent Thalassaemia
- 53:04
- Ай бұрын
joint IACRLRD/IACH webinar
- 47:10
- Ай бұрын
Webinar April 29 2024 Ali Bazarbachi
- 38:16
- 2 ай бұрын
Management of patients receiving antiCD38 (supporting tools on how to manage them, AEs)
- 1:19:14
- 2 ай бұрын
IACH Post EBMT 2024
- 37:23
- 2 ай бұрын
Predictors of Unsustained Measurable Residual Disease Negativity in Patients with Multiple Myeloma
- 47:16
- 2 ай бұрын
Impact of a Best Practices Program in Patients with Relapsed/Refractory MM Receiving Selinexor
- 42:08
- 2 ай бұрын
Influenza Vaccines and Therapy in Allogeneic Hematopoietic Cell Transplant Recipients
- 54:11
- 3 ай бұрын
Nursing Care and Frailty in Myeloma
- 1:47
- 3 ай бұрын
Пікірлер